MedPath

A Comparative Study On Treatment Of Unknown bite By Two Group Of Siddha Medicines

Phase 1
Conditions
Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Registration Number
CTRI/2019/05/018938
Lead Sponsor
ational Institute of Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient suffering from Urticaria,

Willing to Give Blood and Urine Sample For Laboratory Investigation,

Patients willing to attend the OPD,

Patient willing to sign the informed consent stating that he/she will consciously stick to the treatment during 48 days and the patients can opt out of the trail of his/her own conscious discretion.

Exclusion Criteria

Pregnancy and Lactation

Diabetes mellitus

Hypertension

Psychosomatic disorders

Cardiac disease

Hepatic disorders

Any other serious systemic illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rticaria will be assessed by Universal Urticaria assessment scale and reduction of ESR level after treatment. <br/ ><br> <br/ ><br>Timepoint: 48 days
Secondary Outcome Measures
NameTimeMethod
Effectiveness of Gowrichinthamani chendooram with thirikaduku chooranam (Group I Medicine) and Elathy Chooranam with Palagarai Parpam (Group II Medicine) in UrticariaTimepoint: 48 days
© Copyright 2025. All Rights Reserved by MedPath